| COMPOSITION: | Each g contains Luliconazole 1% w/w & Salicylic Acid 3% w/w |
| FORMULATION: | TOPICAL |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Luliact-S combines an antifungal agent (luliconazole) with a keratolytic agent (salicylic acid) to treat hyperkeratotic tinea infections, such as athlete’s foot, jock itch, and ringworm. Luliconazole inhibits fungal cell membrane synthesis, while salicylic acid softens and removes thickened skin layers, enhancing drug penetration and efficacy. |
| SIDE EFFECTS: | Common reactions include mild skin irritation, redness, itching, or stinging at the application site. Serious side effects are rare but may involve allergic reactions such as swelling of the face, lips, or tongue. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
